HRP20251406T1 - Angiotenzin ii sam ili u kombinaciji za liječenje hipotenzije - Google Patents
Angiotenzin ii sam ili u kombinaciji za liječenje hipotenzijeInfo
- Publication number
- HRP20251406T1 HRP20251406T1 HRP20251406TT HRP20251406T HRP20251406T1 HR P20251406 T1 HRP20251406 T1 HR P20251406T1 HR P20251406T T HRP20251406T T HR P20251406TT HR P20251406 T HRP20251406 T HR P20251406T HR P20251406 T1 HRP20251406 T1 HR P20251406T1
- Authority
- HR
- Croatia
- Prior art keywords
- hypotension
- angiotensin
- alone
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361917576P | 2013-12-18 | 2013-12-18 | |
| US201461955706P | 2014-03-19 | 2014-03-19 | |
| EP19197866.7A EP3607962B1 (en) | 2013-12-18 | 2014-12-18 | Angiotensin ii alone or in combination for the treatment of hypotension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20251406T1 true HRP20251406T1 (hr) | 2026-02-27 |
Family
ID=53367119
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20251406TT HRP20251406T1 (hr) | 2013-12-18 | 2014-12-18 | Angiotenzin ii sam ili u kombinaciji za liječenje hipotenzije |
| HRP20200009TT HRP20200009T1 (hr) | 2013-12-18 | 2014-12-18 | Angiotenzin ii u kombinaciji za liječenje hipotenzije |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20200009TT HRP20200009T1 (hr) | 2013-12-18 | 2014-12-18 | Angiotenzin ii u kombinaciji za liječenje hipotenzije |
Country Status (25)
| Country | Link |
|---|---|
| US (7) | US9220745B2 (enExample) |
| EP (2) | EP2986308B1 (enExample) |
| JP (4) | JP6824739B2 (enExample) |
| KR (4) | KR20230051721A (enExample) |
| CN (4) | CN111920939A (enExample) |
| AU (3) | AU2014364528C1 (enExample) |
| BR (1) | BR112016013961A2 (enExample) |
| CA (1) | CA2933601A1 (enExample) |
| CY (1) | CY1122604T1 (enExample) |
| DK (2) | DK2986308T3 (enExample) |
| EA (1) | EA037823B1 (enExample) |
| ES (2) | ES3055611T3 (enExample) |
| FI (1) | FI3607962T3 (enExample) |
| HR (2) | HRP20251406T1 (enExample) |
| HU (1) | HUE047062T2 (enExample) |
| IL (1) | IL246162B (enExample) |
| LT (2) | LT2986308T (enExample) |
| MX (2) | MX380968B (enExample) |
| NZ (1) | NZ721089A (enExample) |
| PL (2) | PL3607962T3 (enExample) |
| PT (2) | PT3607962T (enExample) |
| RS (2) | RS59804B1 (enExample) |
| SI (2) | SI2986308T1 (enExample) |
| SM (2) | SMT202000018T1 (enExample) |
| WO (1) | WO2015095535A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9572856B2 (en) | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| LT2986308T (lt) | 2013-12-18 | 2020-03-25 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotenzino ii derinys hipotenzijai gydyti |
| EP3381465A1 (en) * | 2014-07-08 | 2018-10-03 | La Jolla Pharmaceutical Company | Methods for treating hypotension |
| WO2016153558A1 (en) | 2015-03-20 | 2016-09-29 | Atkinson Arthur J | Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps |
| PL3400000T3 (pl) | 2016-01-07 | 2024-04-22 | La Jolla Pharma, Llc | Sposoby podawania angiotensyny ii |
| WO2017120440A1 (en) * | 2016-01-07 | 2017-07-13 | La Jolla Pharmaceutical Company | Methods of administering vasopressors |
| WO2018191678A1 (en) * | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
| TW201927331A (zh) * | 2017-12-15 | 2019-07-16 | 美商拉荷亞製藥公司 | 血管收縮素組合物及與其相關之方法 |
| US20250366467A1 (en) * | 2022-06-15 | 2025-12-04 | Virginia Commonwealth University | Methods for fluid resuscitation of an organ donor |
| JP2025538841A (ja) * | 2022-12-12 | 2025-11-28 | プロレタリアート セラピューティクス， インコーポレイテッド | 心損傷を処置する方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU181008B (en) | 1980-01-18 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position |
| US5216025A (en) | 1989-09-13 | 1993-06-01 | Board Of Regents, The University Of Texas System | Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| CA2448051A1 (en) | 2001-06-04 | 2002-12-12 | Human Genome Sciences, Inc. | Methods and compositions for modulating ace-2 activity |
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| NO20034952D0 (no) | 2003-11-06 | 2003-11-06 | Amersham Health As | Farmasöytiske forbindelser |
| JP2007510643A (ja) | 2003-11-06 | 2007-04-26 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
| FR2880807B1 (fr) * | 2005-01-19 | 2007-04-13 | Aguettant Sa Lab | Composition pharmaceutique injectable |
| EP1942985B1 (en) | 2005-09-29 | 2011-04-27 | Fibrogen, Inc. | Methods for reducing blood pressure |
| WO2007076572A1 (en) | 2005-12-30 | 2007-07-12 | Howard Florey Institute Of Experimental Physiology And Medicine | A method of treatment |
| EP2029137A2 (en) | 2006-06-15 | 2009-03-04 | Gilead Colorado, Inc. | Antihypertensive therapy method |
| WO2008130217A1 (en) * | 2006-08-08 | 2008-10-30 | Applied Nanosystems B.V. | Cyclic angiotensin analogs |
| CA2678131A1 (en) | 2006-11-17 | 2008-05-22 | Antoine Andremont | Colonic delivery using zn/pectin beads with a eudragit coating. |
| WO2009009907A1 (en) * | 2007-07-18 | 2009-01-22 | The University Of British Columbia | Use of vasopressin-receptor agonists for the treatment of septic shock |
| EP2161030A1 (en) * | 2008-09-09 | 2010-03-10 | Rijksuniversiteit te Groningen | Oxytocin formulations and uses thereof |
| AU2009319856A1 (en) | 2008-11-28 | 2010-06-03 | Abbvie Inc. | Stable antibody compositions and methods for stabilizing same |
| US9572856B2 (en) * | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| FR2959414B1 (fr) * | 2010-04-30 | 2016-01-08 | Luc Quintin | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
| BR112013000744A2 (pt) | 2010-07-14 | 2020-07-14 | Cumberland Emerging Technologies, Inc | uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas |
| JP6522584B2 (ja) | 2013-04-26 | 2019-05-29 | ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ | 腎不全を処置するための組成物及び方法 |
| LT2986308T (lt) | 2013-12-18 | 2020-03-25 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotenzino ii derinys hipotenzijai gydyti |
| US20150286797A1 (en) | 2014-04-02 | 2015-10-08 | David R. Ratto | System and method for administering medication |
| EP3381465A1 (en) | 2014-07-08 | 2018-10-03 | La Jolla Pharmaceutical Company | Methods for treating hypotension |
| WO2017120440A1 (en) | 2016-01-07 | 2017-07-13 | La Jolla Pharmaceutical Company | Methods of administering vasopressors |
| PL3400000T3 (pl) | 2016-01-07 | 2024-04-22 | La Jolla Pharma, Llc | Sposoby podawania angiotensyny ii |
| WO2018191678A1 (en) | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
| TW201927331A (zh) | 2017-12-15 | 2019-07-16 | 美商拉荷亞製藥公司 | 血管收縮素組合物及與其相關之方法 |
-
2014
- 2014-12-18 LT LTEP14872684.7T patent/LT2986308T/lt unknown
- 2014-12-18 SI SI201431450T patent/SI2986308T1/sl unknown
- 2014-12-18 FI FIEP19197866.7T patent/FI3607962T3/fi active
- 2014-12-18 EA EA201691258A patent/EA037823B1/ru unknown
- 2014-12-18 CN CN202010824424.5A patent/CN111920939A/zh active Pending
- 2014-12-18 HR HRP20251406TT patent/HRP20251406T1/hr unknown
- 2014-12-18 CA CA2933601A patent/CA2933601A1/en active Pending
- 2014-12-18 ES ES19197866T patent/ES3055611T3/es active Active
- 2014-12-18 AU AU2014364528A patent/AU2014364528C1/en active Active
- 2014-12-18 RS RS20200021A patent/RS59804B1/sr unknown
- 2014-12-18 KR KR1020237012136A patent/KR20230051721A/ko not_active Ceased
- 2014-12-18 KR KR1020247034828A patent/KR20240154702A/ko active Pending
- 2014-12-18 SM SM20200018T patent/SMT202000018T1/it unknown
- 2014-12-18 CN CN202011494632.XA patent/CN112546197A/zh active Pending
- 2014-12-18 SI SI201432120T patent/SI3607962T1/sl unknown
- 2014-12-18 MX MX2016008108A patent/MX380968B/es unknown
- 2014-12-18 EP EP14872684.7A patent/EP2986308B1/en active Active
- 2014-12-18 PT PT191978667T patent/PT3607962T/pt unknown
- 2014-12-18 RS RS20251135A patent/RS67626B1/sr unknown
- 2014-12-18 KR KR1020167019427A patent/KR102399383B1/ko active Active
- 2014-12-18 LT LTEP19197866.7T patent/LT3607962T/lt unknown
- 2014-12-18 EP EP19197866.7A patent/EP3607962B1/en active Active
- 2014-12-18 KR KR1020227004084A patent/KR20220028125A/ko not_active Ceased
- 2014-12-18 DK DK14872684.7T patent/DK2986308T3/da active
- 2014-12-18 ES ES14872684T patent/ES2771749T3/es active Active
- 2014-12-18 PT PT148726847T patent/PT2986308T/pt unknown
- 2014-12-18 BR BR112016013961A patent/BR112016013961A2/pt not_active Application Discontinuation
- 2014-12-18 SM SM20250427T patent/SMT202500427T1/it unknown
- 2014-12-18 PL PL19197866.7T patent/PL3607962T3/pl unknown
- 2014-12-18 HU HUE14872684A patent/HUE047062T2/hu unknown
- 2014-12-18 PL PL14872684T patent/PL2986308T3/pl unknown
- 2014-12-18 US US14/575,127 patent/US9220745B2/en active Active
- 2014-12-18 DK DK19197866.7T patent/DK3607962T3/da active
- 2014-12-18 JP JP2016539318A patent/JP6824739B2/ja active Active
- 2014-12-18 CN CN202411722811.2A patent/CN119700926A/zh active Pending
- 2014-12-18 CN CN201480075899.1A patent/CN106061493A/zh active Pending
- 2014-12-18 NZ NZ721089A patent/NZ721089A/en unknown
- 2014-12-18 HR HRP20200009TT patent/HRP20200009T1/hr unknown
- 2014-12-18 WO PCT/US2014/071186 patent/WO2015095535A1/en not_active Ceased
-
2015
- 2015-11-13 US US14/941,301 patent/US10028995B2/en active Active
-
2016
- 2016-06-09 IL IL246162A patent/IL246162B/en active IP Right Grant
- 2016-06-17 MX MX2020011190A patent/MX2020011190A/es unknown
-
2018
- 2018-03-01 US US15/909,617 patent/US10493124B2/en active Active
- 2018-09-19 US US16/135,608 patent/US10765722B2/en active Active
-
2019
- 2019-04-12 US US16/382,850 patent/US11096983B2/en active Active
- 2019-08-23 JP JP2019153144A patent/JP7175506B2/ja active Active
-
2020
- 2020-01-13 CY CY20201100026T patent/CY1122604T1/el unknown
- 2020-11-26 AU AU2020277230A patent/AU2020277230A1/en not_active Abandoned
-
2021
- 2021-07-20 US US17/380,311 patent/US11559559B2/en active Active
-
2022
- 2022-07-14 JP JP2022113327A patent/JP2022137224A/ja not_active Withdrawn
-
2023
- 2023-01-23 US US18/157,933 patent/US20230226141A1/en not_active Abandoned
-
2024
- 2024-09-18 AU AU2024219851A patent/AU2024219851A1/en active Pending
-
2025
- 2025-05-09 JP JP2025078759A patent/JP2025114753A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3542798T3 (pl) | Aceklidyna do zastosowania w leczeniu starczowzroczności | |
| HRP20251406T1 (hr) | Angiotenzin ii sam ili u kombinaciji za liječenje hipotenzije | |
| EP2989214A4 (en) | IN SITU INTERACTION DETERMINATION | |
| SI3328419T1 (sl) | PD-1-vezavne molekule in postopki uporabe le-teh | |
| IL246141A0 (en) | Methods for adhering tissue surfaces and materials and biomedical uses thereof | |
| HRP20181392T1 (hr) | Heterociklični spojevi i njihova uporaba | |
| HRP20180817T1 (hr) | Sastavi i postupci za modulaciju farnesoid-x-receptora | |
| HUE049637T2 (hu) | Toalettben lehúzható katéterek | |
| IL240845A0 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
| HRP20181628T1 (hr) | Spojevi i postupci za njihovu upotrebu | |
| SI2986304T1 (sl) | Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe | |
| EP2970569A4 (en) | PERSISTENT CARBENE AND COMPOSITIONS WITH IT | |
| IL237421A0 (en) | Topical compositions and methods of use | |
| IL240248A0 (en) | Met-binding agents and uses thereof | |
| BR112016004003A2 (pt) | Composto de tetrazolinona e uso do mesmo | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| DK3044229T3 (da) | Peptider til anvendelse i behandlingen af oral mucositis | |
| EP2959015A4 (en) | CHARACTERIZATION OF MOLECULES IN NANOFLUIDES | |
| PL3042669T3 (pl) | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy | |
| EP2956148A4 (en) | COMPOSITIONS AND METHODS FOR PAIN-LIFTING WITHOUT DEADNESS | |
| DK3071192T3 (da) | Curcuphenolforbindelse til anvendelse i behandling af cancer | |
| BR302014001901S1 (pt) | Configuração aplicada em organizador | |
| HRP20190219T1 (hr) | Spojevi za tretman pretilosti i postupci za njihovu uporabu | |
| FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
| FI20135792A7 (fi) | Lattiakaivon insertti ja lattiakaivo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TUEP | Request for ep validation received |